Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance - Wikidata - wikimedia - TriplyDB

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance

http://www.wikidata.org/entity/Q37618914

about

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment MicroRNA: important player in the pathobiology of multiple myeloma Circulating miRNA markers show promise as new prognosticators for multiple myeloma.A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.MicroRNAome genome: a treasure for cancer diagnosis and therapy.Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.MicroRNAs in urine are not biomarkers of multiple myeloma Up-regulation of serum miR-744 predicts poor prognosis in patients with nasopharyngeal carcinoma A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.The ins and outs of microRNAs as biomarkers in liver disease and transplantation.The potential of miRNAs as biomarkers for multiple myeloma.The mystery of let-7d - a small RNA with great power.The role of circulating miRNAs in multiple myeloma.miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression Prognostic role of circulating exosomal miRNAs in multiple myeloma.Microenvironment drug resistance in multiple myeloma: emerging new players.MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance.Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies Some cautionary notes on the petite "Holy Grail" of molecular diagnostics.Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.Circulating microRNA as Biomarkers in Hematological Malignancies.Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma.

P2860

Q26748881-FFB103D9-182A-4FF4-9A56-CD80316E35BA Q26765477-99BB3AD2-A733-4E8E-966A-0DC439715534 Q33786861-EB8E88FE-5B8A-41D9-BA85-D5098C01E448 Q34135498-241B98CE-BF4B-45CD-B3B2-0BD13A1A6013 Q35176459-909D9B8F-F23A-445C-872A-721D17312D8B Q35211371-F050A123-01FD-4919-BC13-B08E17C16C4C Q35246395-010EC917-CB19-4243-B014-B0757AC1B745 Q35704188-697D6719-CE83-4AEE-AA16-AC9D5621BDD2 Q35781800-E4D84BDC-4D59-4ED0-A2BE-F5E7550EAC5E Q35955237-00F10F5A-B748-46BE-BD30-7278DB981387 Q36089046-20C5C2D6-B27C-4CC8-AFB3-85AD2DDCB399 Q36183019-CE1CB6EB-E4BC-40AB-B988-6D5132EF5BFB Q36199559-D2416371-E95E-4F1E-8D3E-3244A0912A88 Q36240614-817AC623-2E02-4077-9ACF-6457D807CE79 Q36546019-029CBDF0-47BA-4208-8514-B363F8E902B9 Q37190115-D0C392B3-4318-48B3-A5AE-44B14CD15C8E Q37662172-FA7E0240-2A29-4F3D-BB69-C42B076F7DC6 Q37699408-E7E6579D-8A2F-4B5B-BED2-A3C4725A92C0 Q38213075-ADD29981-2AEF-4046-B7C0-FD3D5A9523F6 Q38223103-5CE4D5D3-9970-4275-9AD5-F1F438CAB14A Q38237446-7CE55192-81F5-4C8E-A47B-5F8E8A1EEF01 Q38283518-750BF033-EA78-47D9-9CB9-CD72F32400C3 Q38647786-30E42493-AFE9-4E30-83F9-F667DADE4B4B Q38673891-1CD8A1E7-7DBE-422C-8BFA-DF9C1015A1D3 Q38715962-B92CBD63-1C09-4503-988F-6D7EE6817812 Q38913083-D1A4168E-1361-4DBC-86C2-949CF39B92BE Q39255792-10A006FB-9893-4947-813F-80EEC9BBFD0A Q41390701-62AE70A8-ECEF-4709-8626-4700DFAA45EB Q42421291-E657BEC8-E42D-4DEF-98C2-A8E47E82E30B Q42423819-F556DE31-243D-440F-9D8E-8C6E0641EACE Q46689848-8949CC1A-8B81-48E2-80AD-52298440C811 Q47107152-18CD0AE7-EC88-47F7-B259-0BCDA9E505A1 Q48236958-33873407-6F98-412C-8866-71EB1C788EF5 Q52900367-ED409A5C-A696-4B16-9EDB-6E84EB423D09 Q53420685-D89297E9-AFB7-47EE-A3EC-697DE1075A63 Q55313036-643EBA69-FC1C-44D1-8B66-AA714AE18A4A

P2860

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance

http://www.wikidata.org/entity/Q37618914

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Circulating serum microRNAs as ...... y of undetermined significance

@en

Circulating serum microRNAs as ...... of undetermined significance.

@nl

type

label

Circulating serum microRNAs as ...... y of undetermined significance

@en

Circulating serum microRNAs as ...... of undetermined significance.

@nl

prefLabel

Circulating serum microRNAs as ...... y of undetermined significance

@en

Circulating serum microRNAs as ...... of undetermined significance.

@nl

P1433

Q37618914-F5819DFA-B683-446D-AD7D-A8799F733389

P1476

Q37618914-DCCB5D0B-18B4-4E28-83ED-4920C9B7B76D

P2093

Q37618914-00A6C0F7-AF8B-4C1C-A8E8-E8560CC89C8A

Q37618914-1442F45B-86F6-4EED-8387-8C6245A778E9

Q37618914-1BADBFFB-65EB-4872-94AD-50331F211057

Q37618914-2EF47660-C76B-433B-80B9-D5A73A91D24C

Q37618914-33D7DCD4-77C4-446E-B662-C59FEA117CE5

Q37618914-69DD59C8-0E2C-4E8F-8279-23E298063740

Q37618914-7C07804B-8A0F-4A05-BBEA-C31A29F88B11

Q37618914-9A5C6C00-7B33-49C8-9D3F-B716190785F5

Q37618914-AE7FBBAF-9DE2-47E9-B72B-B83FA7BC2ABD

Q37618914-DE6C4687-C53E-4FBD-A254-B7B78A96032F

P2860

Q37618914-0241EBB9-C459-486D-9B35-14240CB91B97

Q37618914-0431FA7D-2983-4D35-80F8-2EED9013643E

Q37618914-195700E2-8FDF-49F3-AE50-093D8323A96A

Q37618914-339BBE7F-F3CB-4C4A-8C21-24133F344D3F

Q37618914-3B7530FC-8F48-4B20-8632-EE70954A9CE6

Q37618914-49886D8E-E1B4-4BF2-A8B6-DECABF15861C

Q37618914-4BAE8EE2-9B2B-4260-85E6-A3EFB2C3EA00

Q37618914-52B7B8A3-49A8-4D2F-8C80-6F16D9F56ACB

Q37618914-536E1183-1C63-4701-8CC8-7A286DD72DE5

Q37618914-54FBEEB1-D243-4AB8-AA6F-4784B83B1226

P304

Q37618914-7E871598-7621-4A8E-8FCB-7E24D1410687

P31

Q37618914-4F8B684F-E5DE-40C1-9503-45718AE6E1FB

P356

Q37618914-E6E40F65-50B8-4012-816B-D21DDC40C367

P433

Q37618914-3100F4E3-C1D3-4CB3-9A12-0E06F4D0551F

P478

Q37618914-45E56557-CF47-4847-B944-19DF0737AAB1

P50

Q37618914-01EC90B1-C5DB-4FF6-B8A0-B28E8C6C1BBD

Q37618914-AE299C15-7FB9-43D3-B425-2DE0A7DEBCB9

P577

Q37618914-FDD07E7A-0246-4D8C-A8D4-D0057F31BE93

P5875

Q37618914-EF5D845A-EFE0-4F38-9626-BD15346FA1F5

P698

Q37618914-594D9F84-6936-4307-8BA3-A4AAB90A0662

P921

Q37618914-02395ABD-8752-437A-8390-BC5DE272F094

Q37618914-1D9C62FE-658E-49CA-961C-589CD3D22F7E

P932

Q37618914-7D99E48F-93DF-45C7-A861-BD6C26487B19

P356

HAEMATOL.2013.093500

P1433

P1476

Circulating serum microRNAs as ...... y of undetermined significance

@en

P2093

Elena Dementyeva

http://www.w3.org/2001/XMLSchema#string

Eva Vetesnikova

http://www.w3.org/2001/XMLSchema#string

Fedor Kryukov

http://www.w3.org/2001/XMLSchema#string

Henrieta Greslikova

http://www.w3.org/2001/XMLSchema#string

Jiri Jarkovsky

http://www.w3.org/2001/XMLSchema#string

Lenka Kubiczkova

http://www.w3.org/2001/XMLSchema#string

Lenka Radova

http://www.w3.org/2001/XMLSchema#string

Ludek Pour

http://www.w3.org/2001/XMLSchema#string

Ondrej Slaby

http://www.w3.org/2001/XMLSchema#string

Petr Kuglik

http://www.w3.org/2001/XMLSchema#string

P2860

Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line

Serum microRNAs are promising novel biomarkers

Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis

Characterization of extracellular circulating microRNA

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Multiple myeloma

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Oncomirs - microRNAs with a role in cancer

Specificity of microRNA target selection in translational repression

P304

511-518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2013.093500

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Jana Nekvindová

P577

2013-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258636945

http://www.w3.org/2001/XMLSchema#string

P698

24241494

http://www.w3.org/2001/XMLSchema#string

P921

P932

3943315

http://www.w3.org/2001/XMLSchema#string